TokenPost·
Savara Shares Fall 18% After Company Says FDA Will Miss Molgramostim Action Date

The FDA’s review is ongoing, and the agency has not provided a new action date.
Every crypto headline. One feed. Updated every minute.

The FDA’s review is ongoing, and the agency has not provided a new action date.